PSCA and familial pancreatic carcinoma: Functionalized InP/ZnS QDs bioconjugates are prepared by treating QD surfaces with mercaptosuccinic acid followed by bioconjugation with monoclonal antibodies specific to pancreatic cancer, i.e. anti-claudin 4 and anti-prostate stem cell antigen (anti-PSCA) [138].